ALS association ALS association
Stories About

ALS association

A controversial new drug for ALS that just received FDA approval could add months to patients' lives, but some scientists question whether it actually works. Manuel Balce Ceneta/AP hide caption

toggle caption
Manuel Balce Ceneta/AP

ALS drug's approval draws cheers from patients, questions from skeptics

  • Download
  • <iframe src="https://www.npr.org/player/embed/1126267087/1126295756" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The drugmaker Amylyx is asking the FDA to approve a new medication for ALS, a fatal neurodegenerative disease. It's possible the agency could greenlight the drug by the end of the month. Manuel Balce Ceneta/AP hide caption

toggle caption
Manuel Balce Ceneta/AP

FDA seems poised to approve a new drug for ALS, but does it work?

  • Download
  • <iframe src="https://www.npr.org/player/embed/1124138839/1124441200" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript